On March 1, 2023 Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, reported that Sabrina Martucci Johnson, the company’s President and CEO, will present at the 35th Annual Roth Conference, being held March 12-14, 2023 in Laguna Niguel, CA (Press release, Daré Bioscience, MAR 1, 2023, View Source [SID1234628007]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Ms. Johnson’s presentation is scheduled for Tuesday, March 14th at 8:30 a.m. PDT. A live webcast of the presentation will be available at View Source and under "Presentations, Events & Webcasts" in the Investors section of the company’s website at View Source The webcast will be archived in the same section of the Company’s website and available for replay until March 28, 2023.

Members of the company’s management team will be available for one-on-one meetings. Investors attending the conference who are interested in meeting with Daré management may request a meeting by contacting their Roth sales representative.